NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
15 hedge funds and large institutions have $677K invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-9
Holders Change %
-37.5%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Renaissance Technologies
New York
|
+$156K |
2 |
Creative Planning
Overland Park,
Kansas
|
+$96.3K |
3 |
MIG
Mariner Investment Group
Harrison,
New York
|
+$55K |
4 |
SSB
Sandy Spring Bank
Olney,
Maryland
|
+$1K |
5 |
BlackRock
New York
|
+$45 |